A4i is a platform for supporting people with complex behavioural and mental health conditions. Currently, A4i is being used to target the recovery processes in psychosis and schizophrenia, and newly in opioid use disorders.
$65B in healthcare costs and lost productivity
3.8% of all current hospital admissions with 1/12 hospital beds occupied by individuals living with schizophrenia.
7,560 opioid-related deaths in Canada in 2021, 74% of which were accidental.
70% of opioid addictions are related to prescription medications.
Recovery is possible. The mental health landscape is in the middle of an awakening. With a focus on inclusion, support, and healing, A4i has tremendous possibilities to improve the lives of millions of people living with complex mental health challenges while reducing their strain on the healthcare system.
For clinics, clinicians and case managers to coordinate and engage patients with dynamic risk flagging and patient wellness indicators.
A4i will help patients, families, and providers, as we improve outcomes and the bottom line.
Our limitations in better supporting people with illness self-management and challenged treatment engagement, with medications and otherwise, frequently lead to a rapid deterioration in mental health and major setbacks including hospitalizations. Our current efforts, from services to systems, are not enough.
Dr. Sean Kidd,
A4i Chief Scientific Officer
Associate Professor University of Toronto Department of Psychiatry
Chief Psychology Division, CAMH.
Effective care engagement is routinely being challenged.
Current provider constraints limit many aspects of the clinical interaction, including risk identification and care planning, which can leave patients feeling disempowered and disengaged from the treatment process.
Provider-patient interactions are extremely important to clinical outcomes where small improvements can lead to large benefits.
By harnessing patient-generated objective and subjective markers surrounding sleep, mood, medication adherence and app usage to better understand patient status.
Through peer-to-peer anonymized content combined with patient specific intervention messaging, A4i encourages and fosters a supportive and informative community of patients.
Leveraging patient check-in values and application usage data, indicators can be proactively monitored for potential signs of relapse.
Anonymous peer-to-peer support platform and opportunity to safely connect with others.
Curated CBT-based A4i content to address 4 main topics:
Content personalization to help deliver evidence based strategies to enhance wellness and coping
Ambient noise detection for assessing the validity of auditory hallucinations coupled with hallucination detection strategies that help you learn to cope with your hallucinations.
Flexible medication and reminder system to encourage good medication adherence and attendance at appointments.
In application medication adherence messaging with additional escalation to SMS messages.
A4i tracks medication adherence based on interaction and response from the user to track adherence patterns and escalate notifications to clinical staff for low medication adherence
Track mental health and sleep quality through a daily morning check-in.
With the flexibility to choose from preset goals or create ones for yourself, ask A4i to help track your goals for you through an evening check-in.
Mental health and sleep quality trends can be monitored for negative trends that will trigger email notifications to clinical staff.
average likes per user
users liked a post at least once
users shared a post
users would download A4i in the app store
“This app can change lives!”
“the app supports my wellbeing, helps me have peace of mind and staying on track to be well”
“pill reminders and voice recorder – helped sort out what I was hearing was hallucination vs real”
“my favorite features of the app were the feed because I like to read and share and the other is ‘notes to my doc’ which is very helpful – enjoyed how many likes they got on postings”
Read about our accomplishments and exciting upcoming news
A4i Presented at the 2022 ISRII Conference in Pittsburgh – View the Poster
Pilot with Riverside University Health System-Behavioral Health and the CalMHSA Help@Hand
A4i Feasibility Study Publication in PLOS ONE
Winner of Johnson & Johnson @JLABSToronto 2016 Quickfire Challenge
A4i as a CAMH and MEMOTEXT Collaborative Venture
A4i as One of the Ten Startups Changing Healthcare by Scientific American
To learn more about current co-design trial contact us. View posters for patients, care providers and key supports.
Interested in helping to transform #mentalhealth?
Want to test the A4i app?
Have content you want to share with people living with schizophrenia?
Fill in the contact form below with your interest and level of commitment and we will reach out if we have any opportunities available!
Amos Adler
Phone: 1-877-MEMO-TXT
Email: amos@memotext.com
Website: memotext.com
Dr. Klara Vichnevetski
Phone: 416-595-6056
Email: klara.vichnevetski@camh.ca